RingCentral, Inc. (NYSE:RNG), a global leader in AI-powered trusted business communications for companies of all sizes, today announced financial results for the fourth quarter and fiscal year ended ...

Reports Q4 revenue $615M, consensus $612.42M. “We had a good fourth quarter, capping a strong year,” said Vlad Shmunis, RingCentral’s (RNG) ...

Boehringer Ingelheim, IP Group, the UK Respiratory Gene Therapy Consortium (GTC) 1 and OXB, 1 today announce the start of LENTICLAIR TM 1, a Phase I/II trial of BI 3720931, a novel, first-in-class, ...

The AI trade isn't about Nvidia anymore, according to Goldman Sachs. Instead, invest in companies with AI-enabled revenues.

An inhalable medicine with the potential to improve lung disease in people with cystic fibrosis, irrespective of their mutation type, is being tested in human trials in the UK and Europe.

The global Gene Therapy market, valued at US$7.21 billion in 2023, is forecasted to grow at a robust CAGR of 19.4%, reaching ...

After years of living out of suitcases and subletting ... By Matt Yan The Whaling City, home to a diverse food scene, will soon have a new rail connection to Boston. By Josh Ocampo A brick ...

In the fast-paced drone industry, compliance with federal regulations and the use of advanced technology are essential for staying competitive. Esri, the global leader in location intelligence, is now ...

The evolution of cell and gene therapy is reshaping drug discovery, providing new hope for rare diseases and cancer through innovative gene editing approaches.

It's an exciting year that's already seen the likes of Reacher season 3, Severance season 2, and the new animated series Your Friendly Neighborhood Spider-Man. And, the good news is that there's ...